Glen Allen, VA:  According to a new report from industry analyst firm NanoMarkets, the global medical polymer market will grow from $2.3 billion (USD) in 2013 to over $3.5 billion in 2018.  The report titled, “Worldwide Medical Polymer Markets 2013-2020” identifies the current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising.

The report also includes granular eight-year forecasts and an analysis of the complete supply chain for medical polymers.  Firms addressed within the report include, Bayer MaterialScience, Celanese, Dow Corning, Dow Chemical, DSM, DuPont, Eastman Chemical, Evonik, Solvay and others.

Details about the report are available at:

From the Report:

  • Implants currently consume about half the medical polymers produced and are expected to account for around $1.6 billion in polymer sales by 2018. Polymers have been penetrating the implant market because they are lower cost and lighter weight than metal alternatives, such as titanium.  The report also indicates that increased use of medical imaging is creating further demand for polymers.
  • According to the new NanoMarkets report, sales of polymers for diagnostic systems will reach $1.04 billion in 2018. In vitro diagnostics account for 50,000 to 60,000 metric tons of specialized and commodity plastics every year.  Most diagnostic procedures today are rapid, multi-assays, and plastics have become indispensable. The growth prospects in this sector are thus particularly strong.
  • The report claims that PMMA, PS/styrenics, and PP are the leading medical polymers based on revenue accounting for around 26 percent of the market in 2013.  There are also some high-value niches appearing in the market.  Commercial elastomers that provide a “soft touch” are being used to coat accessories, such as catheters, gloves, and syringes, in order to impart a soft touch feel. Their use is expected to grow in intravenous drug delivery systems, cardio systems, and blood collection devices.
  • The last decade has seen the rise of biodegradable polymers. The current trend suggests that in the near future, entire prostheses will be developed from these materials. While they will not be used to manufacture diagnostic products, biodegradable polymers will be incorporated into implants and some clinical labware.  There is some additional interest in discovering new biodegradable polymers for medical applications, but investment in this area is limited due to the need to complete extensive long-term studies in order to validate new materials.

About NanoMarkets:

NanoMarkets tracks and analyzes emerging markets in medical, energy, electronics and other area created by developments in advanced materials. The firm is a recognized leader in industry analysis and forecasts of in the transparent conductor industry and has been actively involved in

Visit for a full listing of NanoMarkets’ reports and other services.


Robert Nolan
(804) 938-0030